Janus Henderson Group
IPXL

Janus Henderson Group’s Impax Laboratories, Inc. IPXL Stock Holding History

Janus Henderson Group’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-397,296
Closed -$7.73M – 1456
2018
Q1 		$7.73M Sell
397,296
-1,014,740
-72% -$19.9M ﹤0.01% 936
2017
Q4 		$23.5M Buy
1,412,036
+4,488
+0.3% +$82.3K 0.01% 726
2017
Q3 		$28.6M Buy
+1,407,548
New +$26.9M 0.02% 648

Janus Henderson Group's IPXL Position: Q2 2018 in Review

Janus Henderson Group sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 397,296 shares — an estimated $7.73M sold.

Janus Henderson Group first reported a position in IPXL in Q3 2017 and held it in 3 quarters. The position peaked at $28.6M in Q3 2017. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • Janus Henderson Group reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • Janus Henderson Group sold 397,296 Impax Laboratories, Inc. shares in Q2 2018, an estimated $7.73M.
  • Janus Henderson Group first reported a position in Impax Laboratories, Inc. in Q3 2017 and held it in 3 quarters.
  • Janus Henderson Group's Impax Laboratories, Inc. position peaked at $28.6M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Janus Henderson Group's 13F filing for Q2 2018, filed 10 Aug 2018.